Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease

Journal of Vascular Surgery

Volumn 58, Issue 2, 2013, Pages 386-395.e4

  Geraghty, Patrick J ^a   Mewissen, Mark W ^b   Jaff, Michael R ^c   Ansel, Gary M ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Luke's Hospital Milwaukee   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d RIVERSIDE METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ANAMNESIS; ARTERIOGRAPHY; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; ENDOPROSTHESIS; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; NITINOL STENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SUPERFICIAL FEMORAL ARTERY;

EID: 84880794093     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2013.01.050     Document Type: Article

References (18)

1. J.A. Dormandy, and R.B. Rutherford Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic InterSociety Concensus (TASC) J Vasc Surg 31 2000 S1 S296
2. M.W. Mewissen Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results Tech Vasc Interv Radiol 7 2004 2 5
3. D. Scheinert, S. Scheinert, J. Sax, C. Piorkowski, S. Braunlich, and M. Ulrich Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
4. T. Jahnke, R. Andresen, S. Muller-Hulsbeck, F.K. Schafer, G. Voshage, and M. Heller Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial J Vasc Interv Radiol 14 2003 41 51
5. R.R. Saxon, J.M. Coffman, J.M. Gooding, E. Natuzzi, and D.J. Ponec Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial J Vasc Interv Radiol 14 2003 303 311
6. R.R. Saxon, M.D. Dake, R.L. Volgelzang, B.T. Katzen, and G.J. Becker Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease J Vasc Interv Radiol 19 2008 823 832
7. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
8. C.A. McHorney, J.E. Ware Jr., J.F. Lu, and C.D. Sherbourne The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care 32 1994 40 66
9. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
10. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 483
11. P.F. Chong, A.M. Garratt, J. Golledge, R.M. Greenhalgh, and A.H. Davies The intermittent claudication questionnaire: a patient-assessed condition-specific health outcome measure J Vasc Surg 36 2002 764 771 discussion: 863-4
12. K.J. Rocha-Singh, M.R. Jaff, T.R. Crabtree, D.A. Bloch, and G. Ansel Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease Catheter Cardiovasc Interv 69 2007 910 919
13. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
14. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
15. P. Dick, H. Wallner, S. Sabeti, C. Loewe, W. Mlekusch, and J. Lammer Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Interv 74 2009 1090 1095
16. W.R. Hiatt, L. Cox, M. Greenwalt, A. Griffin, and C. Schechter Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials Vasc Med 10 2005 207 213
17. E.P. Brass, J. Jiao, and W. Hiatt Optimal assessment of baseline treadmill walking performance in claudication clinical trials Vasc Med 12 2007 97 103
18. T.P. Murphy, D.E. Cutlip, J.G. Regensteiner, E.R. Mohler, D.J. Cohen, and M.R. Reynolds Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study Circulation 125 2012 130 139